Skip to main content

Table 1 Clinical characteristics of pancreatic adenocarcinoma

From: The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma

Clinicopathological variables

n = 184

Age (years)

 < 60

57 (31.0%)

 ≥ 60

127 (69.0%)

Gender

 Male

102 (55.4%)

 Female

82 (44.6%)

Tumor grade

 G1 + G2

129 (70.1%)

 G3 + G4

53 (28.8%)

Pathological tumor size

 T1 + T2

31 (16.8%)

 T3 + T4

151 (82.1%)

Pathological stage

 I + II

172 (93.5%)

 III + IV

9 (4.9%)

 Recurrence

83 (45.1%)

 Death

99 (53.8%)